Regional Analysis
Sodium Phenylbutyrate Market Regional Insights
- North America is the leading market for sodium phenylbutyrate, with a share of 35% in 2022. The high prevalence of UCDs and MSUD in North America and the presence of a large number of key players in the region are the major factors driving the growth of the market in North America.
- Europe is the second-largest market for sodium phenylbutyrate, with a share of 25% in 2022. The rising awareness about the benefits of sodium phenylbutyrate for the treatment of UCDs and MSUD and the increasing number of product approvals in Europe are the major factors driving the growth of the market in the region.
- Asia Pacific is expected to grow at the highest CAGR during the forecast period, with a share of 20% in 2022. The growth of the market in Asia Pacific is driven by the rising awareness about UCDs and MSUD, the increasing number of product approvals, and the presence of a large number of key players in the region.
Figure 2. Global Sodium Phenylbutyrate Market Share (%), By application, 2023
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
U.S.: 
U.K. : 
India : 
